Cart
sales@molnova.com
Ganoderic acid G
CAS No. 98665-22-6
Ganoderic acid G( —— )
Catalog No. M19843 CAS No. 98665-22-6
Ganoderic acid G is a highly oxidized lanostane-type triterpenoid from the fungus ganoderma lucidum.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 221 | In Stock |
|
| 5MG | 169 | In Stock |
|
| 10MG | 268 | In Stock |
|
| 25MG | 451 | In Stock |
|
| 50MG | 646 | In Stock |
|
| 100MG | 919 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameGanoderic acid G
-
NoteResearch use only, not for human use.
-
Brief DescriptionGanoderic acid G is a highly oxidized lanostane-type triterpenoid from the fungus ganoderma lucidum.
-
DescriptionGanoderic acid G is a highly oxidized lanostane-type triterpenoid from the fungus ganoderma lucidum.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number98665-22-6
-
Formula Weight532.67
-
Molecular FormulaC30H44O8
-
Purity>98% (HPLC)
-
SolubilityDMSO:10 mM
-
SMILESC[C@H](CC(=O)CC(C)C(O)=O)[C@H]1CC(=O)[C@@]2(C)C3=C(C(=O)[C@@H](O)[C@]12C)[C@@]1(C)CC[C@H](O)C(C)(C)[C@@H]1C[C@@H]3O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Ganoderic acid G and I and ganolucidic acid A and B new triterpenoids from Ganoderma lucidum.
molnova catalog
related products
-
Thalidomide-O-amido-...
Thalidomide-O-amido-C4-NH2 TFA is a synthesized E3 ligase ligand-linker conjugate.
-
Osteocalcin (45-49) ...
Bone Gla Protein (45-49) is the 45-49 fragment of gamma-carboxyglutamic acid (GLA)-containing protein from bone (BGP, osteocalcin), which has chemotactic activity in vitro for a number of cells which are found adjacent to endosteal bone surfaces in vivo.
-
Divalproex Sodium
Divalproex Sodium binds to and inhibits gamma-aminobutyric acid (GABA) transaminase and its anticonvulsant activity may be exerted by increasing brain concentration of GABA and by inhibiting enzymes that catabolize GABA or block the reuptake of GABA into glia and nerve endings.
